WOSULIN-30/70 DISPOPEN

Composition

Human insulin 30/70 (Biphasic insulin: 30% soluble/regular human insulin + 70% isophane/NPH human insulin); strength per mL not specified

Uses of WOSULIN-30/70 DISPOPEN

Treatment of diabetes mellitus to improve blood glucose control in patients requiring insulin (Type 1 diabetes and insulin-requiring Type 2 diabetes).

• •Controls fasting and post-meal blood sugar
• •Provides dual action (rapid + intermediate) glucose control
• •Helps reduce symptoms/complications of uncontrolled diabetes
• •Convenient prefilled disposable pen for dosing

How it works

Biphasic human insulin provides both rapid and intermediate action. The soluble (regular) component covers post-meal glucose rise, while the NPH (isophane) component provides basal control between meals and overnight by facilitating glucose uptake and reducing hepatic glucose output.

Directions for use

For subcutaneous injection using the prefilled disposable pen as prescribed by a doctor. Usually given 1–2 times daily about 30 minutes before meals; rotate injection sites (abdomen, thigh, upper arm) to reduce lipodystrophy. Do not inject intravenously; check appearance and resuspend as applicable for biphasic insulin before use; follow pen instructions for priming and dosing.

Side effects

Common side effects of WOSULIN-30/70 DISPOPEN may include:

• •Hypoglycaemia
• •injection site pain/redness/swelling
• •